PMID- 15124121 OWN - NLM STAT- MEDLINE DCOM- 20040625 LR - 20070413 IS - 0767-0974 (Print) IS - 0767-0974 (Linking) VI - 20 IP - 4 DP - 2004 Apr TI - [From the conception of the PRINS to its coronation]. PG - 465-73 AB - As a non-isotopic molecular cytogenetic technique, the primed in situ (PRINS) labelling reaction represents a major technological progress achieved in the past decade. It has become a routine technique for the microscopic visualization of specific DNA sequences in cells and nuclei and constitutes a good alternative to the fluorescence in situ hybridization (FISH) procedure. Among the multiple advantages that characterize the PRINS technique, specificity, rapidity, reliability, reproducibility, and cost-effectiveness can be mentioned. PRINS can be in addition associated with other techniques like FISH, indirect immunofluorescence, and nick translation. The most recent developments show the great potential of this technique. Now PRINS can be used to study single-copy genes and, consequently, can be routinely used to investigate deletions associated with microdeletion syndromes. Therefore, the PRINS technique has the potential to become a widely used molecular cytogenetic tool in clinics and research. This short review presents how the PRINS technique contributed to further the understanding of biological phenomena and describes the different possibilities and applications of the PRINS method in several biological and clinical fields (pre-implantation testing, prenatal, constitutional and oncologic genetic diagnosis). FAU - Krabchi, Kada AU - Krabchi K AD - Departement de Pediatrie, Faculte de medecine, Universite de Sherbrooke, Quebec, Canada. FAU - Lavoie, Josee AU - Lavoie J FAU - Coullin, Philippe AU - Coullin P FAU - Bronsard, Marc AU - Bronsard M FAU - Pellestor, Franck AU - Pellestor F FAU - Yan, Ju AU - Yan J FAU - Drouin, Regen AU - Drouin R LA - fre PT - English Abstract PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review TT - De la conception du PRINS a son couronnement. PL - France TA - Med Sci (Paris) JT - Medecine sciences : M/S JID - 8710980 RN - 0 (DNA, Neoplasm) RN - 0 (DNA, Viral) RN - 9007-49-2 (DNA) SB - IM MH - Base Sequence MH - Chromosomes/genetics/ultrastructure MH - DNA/analysis MH - DNA, Neoplasm/analysis MH - DNA, Viral/analysis MH - Fetal Diseases/diagnosis/genetics MH - Fluorescent Antibody Technique MH - Genetic Diseases, Inborn/diagnosis/genetics MH - Humans MH - In Situ Hybridization, Fluorescence MH - Interphase MH - Metaphase MH - Preimplantation Diagnosis/methods MH - Prenatal Diagnosis/methods MH - *Primed In Situ Labeling/methods/trends MH - Sensitivity and Specificity RF - 51 EDAT- 2004/05/05 05:00 MHDA- 2004/06/26 05:00 CRDT- 2004/05/05 05:00 PHST- 2004/05/05 05:00 [pubmed] PHST- 2004/06/26 05:00 [medline] PHST- 2004/05/05 05:00 [entrez] AID - 008123ar [pii] AID - 10.1051/medsci/2004204465 [doi] PST - ppublish SO - Med Sci (Paris). 2004 Apr;20(4):465-73. doi: 10.1051/medsci/2004204465.